Bioengineering the Future of Drug Delivery workshop – Porto

,
Our CEO, Meritxell Teixido, and Chemist Research Scientist Marina Plaza Garrido recently participated…

Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | Boston

,
📅 April 1-3, 2025 📍 Boston, USA We’re excited to share that Gate2Brain will be participating…

Keystone Symposia on Drug Delivery to the Brain: Emerging Modalities

,
Breaking Barriers and Sharing Innovation with Leaders in Brain Drug Delivery At Gate2Brain, we are…

Gate2Brain Named Best Startup of January 2025 at Keiretsu Forum Barcelona

,
Gate2Brain has been honored with the Best Startup Award at the latest Keiretsu Forum in EADA Business…

International Day of Women & Girls in Science

Celebrating Women and Girls in Science! At Gate2Brain, we believe that curiosity, passion, and determination…

Meet Gate2Brain 2024 Interns

,
Last year, Gate2Brain had the honor of welcoming three talented interns from different corners of the…

Meet the Advisory Board – Andrés G. Fernández

, ,
We are continuing to introduce the remarkable individuals who make up Gate2Brain’s external advisory…

Navigating the ecosystem of pharma companies and investors at JP Morgan-RESI

, ,
Navigating the vibrant ecosystem of pharma companies and investors during J.P. Morgan San Francisco and…

Companies to Watch 2025

,
By Dennis Ford, Founder & CEO, Life Science Nation (LSN) Life Science Nation (LSN) has established…

Gate2Brain will be attending RESI JMP San Francisco 2025

,
Gate2Brain will be in San Francisco during  JPM2025,  from the 13th and 17th January 2025. Pitching…

Gate2Brain and its “molecular tractors” technology: new way to optimize the transport of drugs to the brain

,
Article by Andrea Rivero García Meritxell Teixidó, CEO and co-founder of Gate2Brain, explains in an…

G2B among the 6 finalist startups at the Trans-Atlantic Angel Conference

,
Next week, on Thursday, 5th December, the six finalist startups of the Trans-Atlantic Angel Conference…

RESI London 2024

,
Gate2Brain, a cutting-edge technology platform dedicated to overcoming biological barriers—including…

Gate2Brain’s CEO Recognized Among the Top 10 Women Entrepreneurs in Catalonia by EAE Business School

,
Our Co-Founder Meritxell Teixido has been named one of the Top 10 Women Entrepreneurs in Catalonia by…

Gate2Brain Receives EMA Orphan Drug Designation for Its Groundbreaking G2B-002

, ,
PRESS RELEASE Barcelona, November 2024 – Gate2Brain, a cutting-edge technology platform focused on…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social